QuidelOrtho (QDEL) Earnings Forecast
Analysts expect QuidelOrtho (QDEL) to earn $0.67 a share in FY26, from the one published estimate as of Nov 16, 2026.
2 figures withheld by our checks. Each blank figure names its reason.
- FY26 consensus EPS
- $0.67
- 1 analyst
- FY27 consensus EPS
- $1.32
- 1 analyst · low $1.30, high $1.33
Consensus estimates only. Analysts' price forecasts and ratings are not licensed here.
One analyst covers this company. Every figure on this page is that one person's estimate rather than an average of several, and it moves on one change of mind.
Analysts expect QuidelOrtho to earn $0.90 a share in FY30, growing about 8% a year; 1 analyst publishes an estimate for FY30.
Are estimates going up or down lately?
We hold no eps window in 90 days for FY26 yet. Every figure here compares one fiscal period at both ends.
No step line for this window yet. A line needs two nights of one fiscal period inside the window to join, and our record does not hold two.
| EPS | 30 days | 90 daysshown above |
|---|---|---|
| FY261 analyst | Not yetour record does not hold 30 days of this period | Not yetour record does not hold 90 days of this period |
| FY271 analyst | Not yetour record does not hold 30 days of this period | Not yetour record does not hold 90 days of this period |
| Dec '261 analyst | Not yetour record does not hold 30 days of this period | Not yetour record does not hold 90 days of this period |
| Mar '271 analyst | Not yetour record does not hold 30 days of this period | Not yetour record does not hold 90 days of this period |
Measured between two of our own nightly snapshots of one fiscal period, so a new fiscal year entering the view is never read as a revision. Never backfilled. A window still filling says how many days it holds; a blank one means our record is not that long yet.
If the Street is right, what does that imply for the share price?
At 8.6 times earnings, its average over the last five fiscal years, the FY27 consensus of $1.32 works out to $11 a share.
One analyst covers this year, so the estimate is a single number and there is no low to high band to draw around the answer.
Each point on the line is a multiple, and the flag is the price it implies for FY27. Past multiples are context, not a guide to future ones.
This is multiplication, not a forecast. It assumes the market pays the multiple you chose and that the consensus is right. Both are often wrong.
What you pay for the growth
You are paying 15.4 times the FY26 consensus for earnings the one analyst covering it expects to grow about 61% a year to FY28. That is 0.3 times the growth rate.Show the multiple against its own recordHide the multiple record
How much do analysts disagree?
One analyst publishes on each year, so there is no range to draw: the low, the high and the average are one number, and a single mark stands for each year.
The dashed line is FY25 filed $−16.69, on the GAAP basis.
A wide spread is disagreement, not risk; a narrow one is agreement, not accuracy. Later years are always wider because fewer people forecast them. Bars in amber rest on fewer than 15 analysts. The tick on each bar is the average.
Is next quarter a high bar or an easy one?
Analysts expect QuidelOrtho to earn $0.26 a share in the December quarter, the one estimate published. Results are expected by Jan 29, 2027. Last quarter, which ended in March, QuidelOrtho lost $1.35 a share. Analysts had expected $0.36, so it came in 477.9% lower.
low $0.25
A year ago this quarter was a loss, so the change from it is not a percentage and none is printed. Last quarter's comparison is measured against the last estimate we hold for that quarter rather than the one from the night before the report, because the nearest estimate we hold for it was recorded after the company had already reported. For the March quarter, analysts expect a loss of $0.06 a share.
Does QuidelOrtho usually beat or miss?
So far we have checked 1 quarter: the one that ended in March 2026, when QuidelOrtho lost $1.35 a share against the $0.36 analysts expected, 477.9% lower. We add a quarter to this record each time QuidelOrtho reports. The next report is expected by Jan 29, 2027.
We started recording estimates on Nov 16, 2026, so quarters that reported before that date cannot be checked.
−27.5%
Checked against the company's reported figure (GAAP) and the average estimate we recorded the night before its results release. Where analysts' number is on an adjusted basis, we leave the comparison out rather than force it. We started recording estimates for QuidelOrtho on Nov 16, 2026, so earlier quarters cannot be checked, and we never fill them in after the fact. Mar '26 is drawn hollow: we hold no estimate for that quarter recorded strictly before the report, so it is scored against the last estimate we hold rather than the night-before one.
Where the growth comes from
The one analyst covering it expects sales to grow −0.2% in FY27 and EPS 97.7%. Little of it is sales: the net margin moves from 1.8% to 3.5%, and the implied share count from about 67.7M to 67.7M, so these numbers assume the count stands still.Show the decomposition and the margin ladderHide the decomposition
| Revenue growth | −0.2 |
|---|---|
| Net margin change | +97.9 |
| Share count change | 0.0 |
| EPS growth | +97.7 |
Coverage, and the gap to the filing
1 analyst publishes an EPS estimate for FY26 and 2 publish revenue. Consensus figures are on the Street's basis and filed figures are GAAP; we label the gap, we do not explain it away.Show coverage by yearHide the coverage chart
The full consensus, year by year
Coverage thins with distance: 2 revenue estimates for FY26, 1 for FY30.
Out-year bands widen as fewer analysts publish: 1 EPS estimates for FY26, 1 for FY30.
| Fiscal year | Revenue $B | YoY | EPS $ | YoY | EBITDA $B | Net inc. $B | Shares B | Analysts rev · EPS | Fwd P/E |
|---|---|---|---|---|---|---|---|---|---|
| FY25Filed | 2.7 | — | −16.69 | — | — | — | — | as filed | n/m |
| FY26E | 2.52.5 to 2.5 | ▼7.7%a | 0.670.66 to 0.67 | n/ca | 0.6 | 0.0 | 0.07 | 2 · 1 | 15.4× |
| FY27E | 2.52.5 to 2.5 | ▼0.2% | 1.321.30 to 1.33 | ▲97.7% | 0.7 | 0.1 | 0.07 | 2 · 1 | 7.8× |
| FY28E | 2.62.5 to 2.6 | ▲2.7% | 1.711.71 to 1.72 | n/cb | 0.7 | 0.1 | 0.07 | 2 · 2 | 6.0× |
| FY29E | 2.72.7 to 2.7 | n/cb | 1.911.89 to 1.93 | n/cb | 0.7 | 0.1 | 0.07 | 1 · 1 | 5.3× |
| FY30E | 2.82.8 to 2.8 | ▲3.9% | 0.900.89 to 0.91 | ▼52.9% | 0.6 | 0.1 | 0.07 | 1 · 1 | 11.3× |
Average estimate with low to high beneath. Amber counts mark thin coverage and thin rows carry an amber rule. Shares = consensus net income ÷ consensus EPS, a direction rather than a decimal. The filed row's last column is today's price over the last four reported quarters, the one trailing multiple in that column. a This step crosses the seam: last year is a filed GAAP actual and this year is a consensus estimate, so the two are not prepared on one basis. b More than a third of the analyst panel changed between these two years, so the difference of the two averages measures the panel rather than the forecast.
Analysts' price forecasts and grades are not licensed here. This page shows forward consensus estimates only: 1 EPS estimates for FY26, 2 for revenue. Not investment advice.
Common questions
What do analysts expect QuidelOrtho to earn in FY26?
The one analyst covering QuidelOrtho expects it to earn $0.67 a share in FY26, as of Nov 16, 2026.
What is QuidelOrtho's earnings forecast for FY27?
The FY27 consensus for QuidelOrtho is $1.32 a share from 1 analyst, as of Nov 16, 2026.

